期刊文献+

阳离子多肽在中枢神经系统疾病治疗中的应用

Application of Cationic Peptides in Treatment of Central Nervous System Disease
原文传递
导出
摘要 目的重点阐述阳离子多肽(cationic peptide)在中枢神经系统疾病的治疗中的重要作用。方法 通过对近年来国内外相关文献的学习、整理、归纳和总结,较为全面的介绍有关阳离子多肽修饰的药物载体系统在穿透血脑屏障、进行中枢神经系统疾病治疗中的重要作用。结果与结论阳离子多肽作为细胞穿膜肽家族的一员,也是最常用的多肽,在跨血脑屏障入脑转运方面的起到重要作用,为药物治疗中枢神经系统疾病提供了帮助。 Objective To describe the important role of cationic peptides in the treatment of central nervous system diseases. Methods The related literature at home and abroad in recent years were read sorted and summarized. The penetration of cationic peptide modified drug carrier system through the blood brain barrier and its important role in the treatment of central nervous system diseases were comprehensively introduced. Results AND Conclusion Cationic peptide as a member of cell membrane peptides family and also the most commonly used peptide, has an important role in the transport of drugs blood brain through blood brain barrier. It has made a significant contribution to the therapy of central nervous system diseases.
出处 《中国药学杂志》 CAS CSCD 北大核心 2013年第13期1123-1126,共4页 Chinese Pharmaceutical Journal
基金 国家自然科学基金资助项目(81172394)
关键词 阳离子多肽 血脑屏障 中枢神经系统 cationic peptide, blood brain barrier, central nervous system
  • 相关文献

参考文献2

二级参考文献16

  • 1刘敏,郭佑民,杨军乐,郭晓娟,徐敏,段小艺.穿膜肽标记异硫氰酸荧光素及钆喷替酸葡甲胺行MR分子显像的探讨[J].中华放射学杂志,2006,40(2):139-143. 被引量:5
  • 2GUO You-min,LIU Min,YANG Jun-le,GUO Xiao-juan,WANG Si-cen,DUAN Xiao-yi,WANG Peng.Intercellular imaging by a polyarginine derived cell penetrating peptide labeled magnetic resonance contrast agent,diethylenetriamine pentaacetic acid gadolinium[J].Chinese Medical Journal,2007(1):50-55. 被引量:2
  • 3刘敏,郭佑民,王鹏,郭晓娟,杨军乐,王嗣岑,段小艺,徐贵平.基质金属蛋白酶2靶向穿膜肽表征分析及体外显像研究[J].中华医学杂志,2007,87(4):233-239. 被引量:4
  • 4Straub JA,Atdyama A,Parmar P. In vitro plasma metabolism of RMP-7 [ J ]. Pharm Res, 1994,11 ( 1 ) : 1673.
  • 5Dagar S, Sekosan M, Lee KS, et al. VIP receptors as molecular targets of breast cancer: implicatios for targeted imaging and drug delivery [J ]. J Controlled Release ,2001,74( 1 ) : 129.
  • 6Graul A, Leeson P, Castaner J. RMP-7 Brandykinin B2 agonist,Blood brain barrier permeability enhancer [ J ]. Drugs Future,1998,23(1):32.
  • 7Grant R, Walker M, Hadley D, et al. Imaging response to chemotherapy with RMP-7 and carhoplatin in rnalignant glioma:size matters but speed does not [J]. J Neuroonco1,2002,57(3) :241.
  • 8Britz GW, Ghatan S, Spence AM, et al. Intracarotid RMP-7 enhanced indocyanine green staining of tumors in a rat glioma model[J].J Neurooncol, 2002,56 ( 3 ) : 227.
  • 9Barth RF, Yang W,Bartus RT,et al. Neutron capture therapy of intracerebral melanoma: enhanced survival and cure after blood-brain barrier opening to improve delivery of boronophenylalanine[J]. lnt J Radiat Oncol Biol Phys ,2002,52(3) :858.
  • 10Emerich DF, Snodgrass P, Pink M. Central analgesic actions of loperamide following transient permeation of the blood brain bartier with Cereport (RMP-7) [J]. Brain Res, 1998,801 (1-2) :259.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部